Can I still have children? Lymphoma and Fertility

To add insult to injury, when you are diagnosed with cancer, you also need to be aware of your fertility – or ability to have children in the future.



Treatments for lymphoma include chemotherapy, radiotherapy and bone marrow or stem cell transplants. Each of these treatments can kill the sperms and eggs that are responsible for an individual's fertility. This can prevent the individual from being able to have children in the future.



Infertility after chemotherapy depends on the combination of drugs being used. Some drugs are more likely to cause infertility than others. Radiation causes infertility if it is delivered to the pelvic or groin area. Radiation at other sites like the neck or chest does not cause infertility. Bone marrow or stem cell transplant involves intense chemotherapy and is very likely to cause infertility.



Having lymphoma does not necessarily mean you will never be able to have children. Look here for the latest in support, education and resources for everything you need to know about your fertility and lymphoma.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap